BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 22, 2007
View Archived Issues
Neuromed Raises $53.3M To Push Its Pain Program
Neuromed Pharmaceuticals Inc. closed a $53.3 million Series E financing, bringing the company's running total of venture capital raised to date to more than $126 million. (BioWorld Today)
Read More
Medicure Raises $40 Million To Advance Its Cardio Drugs
Read More
Genta 'Optimistic' Going Into Confirmatory Genasense Study
Read More
Oncoscience Starts Phase III Trials Of YM's Nimotuzumab
Read More
Clinic Roundup
Read More
Other News To Note
Read More